Literature DB >> 18275345

Cross-sectional study of endothelial function in HIV-infected patients in Brazil.

Ana Cristina O Andrade1, Ana Marice Ladeia, Eduardo M Netto, Amanda Mascarenhas, Bruno Cotter, Constance A Benson, Roberto Badaró.   

Abstract

Antiretroviral therapy (ART) in HIV-infected patients has been associated with an increased risk of cardiovascular disease. This study evaluates vascular endothelial dysfunction of the peripheral circulation in Brazilian HIV-infected subjects on ART or naive to ART compared to a control group matched for age and body mass index (BMI). We performed a cross-sectional comparative study to measure postischemic peak flow-mediated dilation (FMD) of the brachial artery and the response to glyceryl trinitrate (GTN) in HIV-infected patients and healthy controls in Salvador, Bahia, Brazil. Endothelial vasomotor function was evaluated by assessing brachial artery FMD. Forty-four HIV-infected individuals (33 ARV treated and 11 ART naive) were compared to 25 healthy controls matched for age and BMI. FMD % was significantly lower for the ART-experienced patients compared to the ART-naive patients and was also significantly different from controls (ART experienced 8.2 +/- 6.0% vs. 19.3 +/- 4.8% vs. 23.3 +/- 6.1%), respectively (p < 0.0001). The cholesterol, triglyceride, and ALT levels were significantly higher in the ART-experienced group compared to the ART-naive and control subjects (p < 0.028); however, linear regression analysis revealed a statistically significant association of endothelial dysfunction as a dependent variable only with ARV treatment in HIV-infected subjects (p = 0.03). The association of endothelial dysfunction with ARV therapy in HIV-infected patients was independent of protease inhibitor-containing regimens or dyslipidemia. This dysfunction may contribute to the risk for HIV-associated atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18275345     DOI: 10.1089/aid.2006.0281

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  Coronary artery endothelial dysfunction is present in HIV-positive individuals without significant coronary artery disease.

Authors:  Micaela Iantorno; Michael Schär; Sahar Soleimanifard; Todd T Brown; Richard Moore; Patricia Barditch-Crovo; Matthias Stuber; Shenghan Lai; Gary Gerstenblith; Robert G Weiss; Allison G Hays
Journal:  AIDS       Date:  2017-06-01       Impact factor: 4.177

Review 2.  Trends and Clinical Characteristics of HIV and Cerebrovascular Disease in Low- and Middle-Income Countries (LMICs) Between 1990 and 2021.

Authors:  George Ransley; Stanley Zimba; Yohane Gadama; Deanna Saylor; Laura Benjamin
Journal:  Curr HIV/AIDS Rep       Date:  2022-10-20       Impact factor: 5.495

3.  Intima-Media Thickness in the Carotid and Femoral Arteries for Detection of Arteriosclerosis in Human Immunodeficiency Virus-Positive Individuals.

Authors:  Emmanuelle Tenório Albuquerque Madruga Godoi; Carlos Teixeira Brandt; Heloisa Ramos Lacerda; Jocelene Tenório Albuquerque Madruga Godoi; Dinaldo Cavalcanti de Oliveira; Gabriela Farias Araujo Sousa Costa; Gerson Gomes Dos Santos Junior; Kaliene Maria Estevão Leite; Juannicelle Tenório Albuquerque Madruga Godoi; Adriana Ferraz de Vasconcelos
Journal:  Arq Bras Cardiol       Date:  2017-01       Impact factor: 2.000

4.  HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress.

Authors:  Andrew Dysangco; Ziyue Liu; James H Stein; Michael P Dubé; Samir K Gupta
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

Review 5.  HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women.

Authors:  Laszlo Kovacs; Taylor C Kress; Eric J Belin de Chantemèle
Journal:  JACC Basic Transl Sci       Date:  2022-01-19

6.  Long-term use of first-line highly active antiretroviral therapy is not associated with carotid artery stiffness in human immunodeficiency virus-positive patients.

Authors:  Haohui Zhu; Jianjun Yuan; Yisa Wang; Fan Gao; Xiao Wang; Changhua Wei; Jiyun Chen; Xiaohui Fan; Mei Zhang
Journal:  Braz J Infect Dis       Date:  2014-05-10       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.